This compound is an active pharmaceutical ingredient standard, identified as a triazole derivative with a difluorophenyl group. It is primarily used as a reference material in pharmaceutical manufacturing and quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 133775-25-4
2-[4-[3-(3,4-Dichlorophenyl)-3-oxo-1-propen-1-yl]phenoxy]acetic Acid
pharmaceutical raw material
Iron(3+) 2-hydroxypropane-1,2,3-tricarboxylate--hexitol (1/1/1)
pharmaceutical raw material
Safinamide
pharmaceutical raw material
Valnemulin hydrochloride
pharmaceutical raw material
Aristolactam I
pharmaceutical raw material
(alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanenitrile
pharmaceutical intermediate
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanamide
research compound
(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1,2,4-triazol-1-yl)butanethioamide
pharmaceutical intermediate
(2R,3R)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butane-2,3-diol
LSCNANBNVFQJDJ-PRHODGIISA-N
C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)O